Susquehanna International Group, LLP Nex Immune, Inc. Transaction History

Susquehanna International Group, LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.2 - $0.3 $4,881 - $7,322	24,407 Added 221.6%	35,421 $7,000
Q2 2023 Aug 11, 2023	BUY	$0.26 - $0.47 $2,863 - $5,176	11,014 New	11,014 $3,000
Q3 2022 Nov 14, 2022	SELL	$0.6 - $17.5 $7,580 - $221,095	-12,634 Reduced 47.44%	13,995 $8,000
Q2 2022 Aug 15, 2022	BUY	$1.61 - $4.68 $42,872 - $124,623	26,629 New	26,629 $43,000

Ticker NEXI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,155,600
Market Cap $7.25M
Description
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's pr...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.